Compare LIVN & HWKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LIVN | HWKN |
|---|---|---|
| Founded | 1987 | 1938 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Specialty Chemicals |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.5B | 2.8B |
| IPO Year | 2015 | 1995 |
| Metric | LIVN | HWKN |
|---|---|---|
| Price | $63.84 | $141.37 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 2 |
| Target Price | $72.43 | ★ $200.00 |
| AVG Volume (30 Days) | ★ 891.2K | 117.4K |
| Earning Date | 05-06-2026 | 05-13-2026 |
| Dividend Yield | N/A | ★ 0.57% |
| EPS Growth | N/A | ★ 12.26 |
| EPS | N/A | ★ 3.17 |
| Revenue | N/A | ★ $974,431,000.00 |
| Revenue This Year | $9.43 | $12.37 |
| Revenue Next Year | $6.85 | $6.30 |
| P/E Ratio | ★ N/A | $41.65 |
| Revenue Growth | N/A | ★ 6.01 |
| 52 Week Low | $32.48 | $102.00 |
| 52 Week High | $71.58 | $186.15 |
| Indicator | LIVN | HWKN |
|---|---|---|
| Relative Strength Index (RSI) | 49.28 | 46.84 |
| Support Level | $63.13 | $120.35 |
| Resistance Level | $65.25 | $155.66 |
| Average True Range (ATR) | 1.95 | 6.41 |
| MACD | -0.04 | -1.30 |
| Stochastic Oscillator | 54.67 | 44.54 |
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers. The majority of revenue is gained from Water Treatment.